• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Align Technology Showcases Digital Dentistry Innovations at Greater New York Dental Meeting 2025

    12/3/25 3:55:00 PM ET
    $ALGN
    Industrial Specialties
    Health Care
    Get the next $ALGN alert in real time by email

    Booth presentations and clinical education sessions highlighted Align™ Digital Platform innovations to empower dental professionals and advance Invisalign® treatment experiences

    Align Technology, Inc. (NASDAQ:ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software, today shared highlights from its participation at the Greater New York Dental Meeting (GNYDM) 2025, one of the largest annual dental congresses in the United States.

    This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251203896223/en/

    Align showcased its latest innovations in digital dentistry across the Align™ Digital Platform – a unique combination of software, systems and services designed to provide a seamless experience and end-to-end workflow that integrates and connects all users – doctors, labs, patients, and consumers

    Align showcased its latest innovations in digital dentistry across the Align™ Digital Platform – a unique combination of software, systems and services designed to provide a seamless experience and end-to-end workflow that integrates and connects all users – doctors, labs, patients, and consumers

    Align showcased its latest innovations in digital dentistry across the Align™ Digital Platform – a unique combination of software, systems and services designed to provide a seamless experience and end-to-end workflow that integrates and connects all users – doctors, labs, patients, and consumers.

    exocad, an Align Technology company, also exhibited at GNYDM and showcased its latest software release: DentalCAD® 3.3 Chemnitz. This latest version delivers a substantially upgraded Implant Module, a new split denture design workflow, and access to the new AI-enabled multi-unit design*.

    At the event, Align and exocad hosted a series of educational sessions designed to help dental professionals enhance clinical outcomes, patient treatment experiences, and practice growth.

    Align's booth featured hands-on experiences with its most advanced innovations, including:

    • iTero Lumina™ scanner: Powered by iTero Multi-Direct Capture™ technology with 3x larger field of view1, and maximum capture distance of 25mm2, designed to scan 2x faster2 and simplify the capture of challenging areas for dentures, palates, edentulous spaces, and other complex cases. Facilitates the capture of all case types and supports highly efficient workflows. Superior full jaw clinical accuracy compared to tested intraoral scanners3 - iTero Lumina™ solutions enable predictable and repeatable first-time restoration fit4 from single unit crowns to removable prosthetics.
    • Align™ Oral Health Suite: Comparison tools that aid in multi-modality assessments and personalized oral health reports. Align™ Oral Health Suite enhances patient-driven interest and engagement with iTero Element™ Plus series and iTero Lumina™ scan images set up within clinical findings to help drive doctor-patient conversations about treatment options. The all-in-one chairside consultation can help patients see the possible oral health conditions and associated root causes.
    • Invisalign Smile Architect™: Treatment planning software now with Multiple Treatment Plans, allowing doctors to visually compare and modify orthodontic only and ortho restorative treatment plans side-by-side. The Multiple Treatment Plans are integrated into ClinCheck® treatment planning software for doctors to visually compare, review, and choose the best treatment option for each patient.
    • iTero™ Design Suite: Software innovation designed to help doctors boost their practice efficiency and elevate patient experiences by shortening time to treatment through an intuitive way to design for in-practice 3D printing. The iTero Design Suite enhances the Align™ Digital Platform, which provides an innovative portfolio of customer-focused technologies that enable seamless end-to-end workflows for dental professionals.
    • ClinCheck® Signature experience: A faster, live, and more tailored approach to treatment planning with confidence, now available globally and includes the ClinCheck® Live family of innovations. Powered by tools like the Invisalign® Personalized Plan, ClinCheck® Pro, Flex Rx, ClinCheck® Live Update, and ClinCheck® Live Plan, this workflow allows doctors to spend less time on revisions and more time with patients.

    Align also sponsored multiple clinical education sessions led by industry experts:

    • Driving Practice Productivity & Growth with Invisalign® Treatment — Nicole Rouleau
    • Simplifying Diagnosis and Case Planning — Dr. Corey Anolik
    • Bridging Ortho and Restorative: A Digital Approach to Treatment Planning — Dr. Steven Glassman
    • Empowering Treatment Decisions Through Modern Patient Education and Digital Workflows — Dr. Michael DiTolla

    "It was a pleasure to meet with doctors and their teams to discuss how Align's innovations can enhance treatment planning, practice workflows, and above all treatment experiences that transform smiles for patients of all ages," said Frank Quinn, Align Technology EVP and managing director, Americas. "We are grateful to the expert Invisalign trained doctors for leading impactful clinical education sessions and to all the attendees who joined us. We look forward to sharing Align's digital dentistry innovations at events and educational sessions."

    *Available in selected markets

    1. Compared to the field of view of the iTero Element™ 5D dental imaging system, when the iTero Lumina™ intraoral scanner's scanning distance is 12 mm. Data on file at Align Technology, as of November 15, 2023.
    2. Compared to the iTero Element™ 5D dental imaging system with tolerance AVE=±0.1 operating at a working distance from 0-20 mm. Data on file at Align Technology, as of November 15, 2023.
    3. Based on bench testing conducted using ADA/ANSI 132 standard Model simulating "long distance accuracy (full jaw measurement)" in July 2024. Method: Comparative test to evaluate full arch accuracy (global accuracy), repeatability and reproducibility of intraoral scanners as described in ADA standard 132 [2015]; Sample definition: 3 operators performed 30 repetitive scans with each tested scanner.; Sample size: n=90 (3x30) scans for each scanner tested; Tested scanners: iTero Lumina; Trios 5; CS3800; Medit i700; Allied Star; Results: The accuracy of iTero Lumina is significantly higher than that of all 4 other scanners; with a reduction of total error ranging from 0.11% to 0.46%. Accuracy was defined as the accumulated average error + STD of all measurements specified in the standard. Data on file at Align Technology, as of August 26, 2024.
    4. Based on bench testing conducted in June 2024 according to ADA/ ANSI 132 standard requirements for long distance full jaw accuracy (average error =0.03% - 0.24% < 0.25%), crown accuracy (average error =0% - 0.9% < 1%) and inlay accuracy specimens (average error =0% - 0.4% < 1%). Data on file at Align Technology, as of August 26, 2024.

    About Align Technology, Inc.

    Align Technology designs and manufactures the Invisalign® System, the most advanced clear aligner system in the world, iTero™ intraoral scanners and services, and exocad™ CAD/CAM software. These technology building blocks enable enhanced digital orthodontic and restorative workflows to improve patient outcomes and practice efficiencies for approximately 291 thousand doctor customers and are key to accessing Align's 600 million consumer market opportunity worldwide. Over the past 28 years, Align has helped doctors treat over 21.4 million patients with the Invisalign System and is driving the evolution in digital dentistry through the Align™ Digital Platform, our integrated suite of unique, proprietary technologies and services delivered as a seamless, end-to-end solution for patients and consumers, orthodontists and GP dentists, and lab/partners. Visit www.aligntech.com for more information.

    For additional information about the Invisalign System or to find an Invisalign doctor in your area, please visit www.invisalign.com. For additional information about the iTero digital scanning system, please visit www.itero.com. For additional information about exocad dental CAD/CAM offerings and a list of exocad reseller partners, please visit www.exocad.com.

    Invisalign, iTero, exocad, Align, Align Digital Platform and iTero Lumina are trademarks of Align Technology, Inc.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20251203896223/en/

    Align Technology

    Madelyn Valente

    (909) 833-5839

    [email protected]

    Zeno Group

    Sarah Karlson

    (828) 551-4201

    [email protected]

    Get the next $ALGN alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ALGN

    DatePrice TargetRatingAnalyst
    12/9/2025$170.00Equal Weight
    Barclays
    10/10/2025$140.00Buy → Hold
    Jefferies
    7/31/2025$154.00Overweight → Equal-Weight
    Morgan Stanley
    4/25/2025$170.00Buy → Hold
    HSBC Securities
    2/14/2025$255.00Overweight
    Wells Fargo
    1/6/2025$235.00 → $280.00Market Perform → Outperform
    Leerink Partners
    12/4/2024$295.00Outperform
    Mizuho
    10/10/2024Hold
    Needham
    More analyst ratings

    $ALGN
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EVP, CHIEF LEGAL & REGULATORY Coletti Julie Ann bought $4,606 worth of shares (42 units at $109.66), increasing direct ownership by 0.59% to 7,110 units (SEC Form 4)

    4 - ALIGN TECHNOLOGY INC (0001097149) (Issuer)

    8/1/25 5:58:45 PM ET
    $ALGN
    Industrial Specialties
    Health Care

    PRESIDENT AND CEO Hogan Joseph M bought $996,131 worth of shares (7,576 units at $131.49), increasing direct ownership by 4% to 184,945 units (SEC Form 4)

    4 - ALIGN TECHNOLOGY INC (0001097149) (Issuer)

    8/1/25 4:05:18 PM ET
    $ALGN
    Industrial Specialties
    Health Care

    Director Larkin C Raymond Jr bought $1,529,645 worth of shares (6,500 units at $235.33) and gifted 4,650 shares, increasing direct ownership by 9% to 23,597 units (SEC Form 4)

    4 - ALIGN TECHNOLOGY INC (0001097149) (Issuer)

    8/19/24 6:35:02 PM ET
    $ALGN
    Industrial Specialties
    Health Care

    $ALGN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Barclays initiated coverage on Align Tech with a new price target

    Barclays initiated coverage of Align Tech with a rating of Equal Weight and set a new price target of $170.00

    12/9/25 8:42:11 AM ET
    $ALGN
    Industrial Specialties
    Health Care

    Align Tech downgraded by Jefferies with a new price target

    Jefferies downgraded Align Tech from Buy to Hold and set a new price target of $140.00

    10/10/25 8:22:21 AM ET
    $ALGN
    Industrial Specialties
    Health Care

    Align Tech downgraded by Morgan Stanley with a new price target

    Morgan Stanley downgraded Align Tech from Overweight to Equal-Weight and set a new price target of $154.00

    7/31/25 7:16:13 AM ET
    $ALGN
    Industrial Specialties
    Health Care

    $ALGN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EVP, CHIEF LEGAL & REGULATORY Coletti Julie Ann bought $4,606 worth of shares (42 units at $109.66), increasing direct ownership by 0.59% to 7,110 units (SEC Form 4)

    4 - ALIGN TECHNOLOGY INC (0001097149) (Issuer)

    8/1/25 5:58:45 PM ET
    $ALGN
    Industrial Specialties
    Health Care

    PRESIDENT AND CEO Hogan Joseph M bought $996,131 worth of shares (7,576 units at $131.49), increasing direct ownership by 4% to 184,945 units (SEC Form 4)

    4 - ALIGN TECHNOLOGY INC (0001097149) (Issuer)

    8/1/25 4:05:18 PM ET
    $ALGN
    Industrial Specialties
    Health Care

    SEC Form 4 filed by Director Vitalone Britt J.

    4 - ALIGN TECHNOLOGY INC (0001097149) (Issuer)

    7/7/25 4:13:42 PM ET
    $ALGN
    Industrial Specialties
    Health Care

    $ALGN
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Align Technology Announces Invisalign® System With Mandibular Advancement Featuring Occlusal Blocks for Class II Skeletal and Dental Correction

    Offers an Innovative Treatment Option for Class II Skeletal Malocclusion in Kids and Teenage Patients While Simultaneously Straightening their Teeth Align Technology, Inc. (NASDAQ:ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced commercial availability in Thailand of the Invisalign System with mandibular advancement featuring occlusal blocks designed specifically to address Class II skeletal and dental correction by simultaneously advancing the mandible while aligning the teeth. This innovat

    12/8/25 9:00:00 PM ET
    $ALGN
    Industrial Specialties
    Health Care

    Align Technology Showcases Digital Dentistry Innovations at Greater New York Dental Meeting 2025

    Booth presentations and clinical education sessions highlighted Align™ Digital Platform innovations to empower dental professionals and advance Invisalign® treatment experiences Align Technology, Inc. (NASDAQ:ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software, today shared highlights from its participation at the Greater New York Dental Meeting (GNYDM) 2025, one of the largest annual dental congresses in the United States. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251203896223/en/Align showcase

    12/3/25 3:55:00 PM ET
    $ALGN
    Industrial Specialties
    Health Care

    Align Technology Recognized for the 3rd Time in Extel's 2025 All-America Executive Team Rankings, Including the Most Honored Company Distinction

    Company, board of directors, and executives earns multiple #1, #3 and top 10 rankings across leadership, governance, and investor relations categories in the Health Care Technology & Distribution sector and Large-Cap ($10B–$50B) market segment Align Technology, Inc. ("Align") (NASDAQ:ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced top-tier recognition in the 2025 All-America Executive Team rankings published by Extel Insights (formerly Institutional Investor Research), which evaluates the qu

    11/25/25 7:02:00 PM ET
    $ALGN
    Industrial Specialties
    Health Care

    $ALGN
    SEC Filings

    View All

    SEC Form 10-Q filed by Align Technology Inc.

    10-Q - ALIGN TECHNOLOGY INC (0001097149) (Filer)

    11/5/25 4:06:43 PM ET
    $ALGN
    Industrial Specialties
    Health Care

    Align Technology Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - ALIGN TECHNOLOGY INC (0001097149) (Filer)

    10/29/25 4:05:15 PM ET
    $ALGN
    Industrial Specialties
    Health Care

    Align Technology Inc. filed SEC Form 8-K: Leadership Update

    8-K - ALIGN TECHNOLOGY INC (0001097149) (Filer)

    9/18/25 5:04:39 PM ET
    $ALGN
    Industrial Specialties
    Health Care

    $ALGN
    Leadership Updates

    Live Leadership Updates

    View All

    Align Technology's Invisalign® Brand Announces Official Sponsorship of Bay FC

    Sponsorship of National Women's Soccer League (NWSL) team highlights inspirational smile stories of women in sports and will help expand access to youth sports across the Bay Area Bay FC, the professional soccer franchise representing the San Francisco Bay Area in the National Women's Soccer League (NWSL), and Align Technology, a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that Align Technology's Invisalign brand is an Official Partner of Bay FC. Through the sponsorship, Bay FC players who are

    3/25/25 4:00:00 PM ET
    $ALGN
    Industrial Specialties
    Health Care

    Align Technology Appoints Emory Wright, EVP Direct Fabrication Manufacturing Platform to Build the Company's Next Generation Manufacturing Operations -- Wright Plans to Retire in 2026

    Align Technology, Inc. (NASDAQ:ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® system of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced it has appointed Emory Wright, executive vice president, direct fabrication manufacturing platform, effective immediately. Mr. Wright will transition his current responsibilities for global operations, including treatment planning, and focus on scaling Align's next generation direct fabrication manufacturing platform, working in close collaboration with Srini Kaza, who was promoted to executive vice president, res

    5/22/24 5:00:00 PM ET
    $ALGN
    Industrial Specialties
    Health Care

    Align Technology Appoints Karim Boussebaa, EVP and MD of iTero Scanner and Services Business—Yuval Shaked to Leave Align End of 2023

    Align Technology, Inc. (NASDAQ:ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® system of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that after nearly six years with Align, Yuval Shaked, executive vice president and managing director of iTero scanner and services, has decided to leave the company for personal reasons and spend more time with his family. He will remain with Align and continue as a member of Align Technology President and CEO Joe Hogan's staff supporting strategic initiatives and programs through 2023. Mr. Shaked will transition

    2/8/23 4:55:00 PM ET
    $ALGN
    Industrial Specialties
    Health Care

    $ALGN
    Financials

    Live finance-specific insights

    View All

    Align Technology Announces Third Quarter 2025 Financial Results

    Q3'25 total revenues were $995.7 million, up 1.8% year-over-year and down 1.7% sequentially, as expected, and above our guidance Q3'25 Clear Aligner volume increased 4.9% year-over-year reflecting strength internationally, and increased 0.5% sequentially reflecting strength from teens and kids Q3'25 Clear Aligner volume for teens and kids increased 8.3% year-over-year and 14.7% sequentially, driven by increased doctor submitters and continued adoption of Invisalign First™ Q3'25 total revenues were $995.7 million, up 1.8% year-over-year and down 1.7% sequentially, as expected, and above our Q3'25 outlook range of $965 million to $985 million Q3'25 total revenues were favorably impa

    10/29/25 4:03:00 PM ET
    $ALGN
    Industrial Specialties
    Health Care

    Align Technology to Announce Third Quarter 2025 Results on October 29, 2025

    Align Technology, Inc. (NASDAQ:ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that it will report third quarter 2025 financial results on Wednesday, October 29, 2025, after the close of market. Financial results will be released at 4:00 p.m. ET (1:00 p.m. PT) and will be available on the Investor Relations section of the Align website at http://investor.aligntech.com. Following the press release, Align will host a conference call to discuss its financial results. The conference call will b

    10/1/25 8:30:00 AM ET
    $ALGN
    Industrial Specialties
    Health Care

    Align Technology Announces Second Quarter 2025 Financial Results

    Q2'25 total revenues were $1,012.4 million, up 3.4% sequentially and down 1.6% year-over-year Q2'25 total revenues were favorably impacted by foreign exchange by approximately $26.4 million, or 2.7% sequentially, and favorably impacted by approximately $5.6 million, or 0.6% year-over-year(1) Q2'25 Clear Aligner revenues were $804.6 million, up 1.0% sequentially and down 3.3% year-over-year Q2'25 Clear Aligner volume was 644.4 thousand cases, up 0.3% sequentially and year-over-year Q2'25 Imaging Systems and CAD/CAM Services revenues were $207.8 million, up 13.9% sequentially and up 5.6% year-over-year Q2'25 operating income of $163.0 million and operating margin of 16.1%, non

    7/30/25 4:14:00 PM ET
    $ALGN
    Industrial Specialties
    Health Care

    $ALGN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Align Technology Inc. (Amendment)

    SC 13G/A - ALIGN TECHNOLOGY INC (0001097149) (Subject)

    2/13/24 4:59:02 PM ET
    $ALGN
    Industrial Specialties
    Health Care

    SEC Form SC 13G/A filed by Align Technology Inc. (Amendment)

    SC 13G/A - ALIGN TECHNOLOGY INC (0001097149) (Subject)

    2/9/24 4:31:42 PM ET
    $ALGN
    Industrial Specialties
    Health Care

    SEC Form SC 13G/A filed by Align Technology Inc. (Amendment)

    SC 13G/A - ALIGN TECHNOLOGY INC (0001097149) (Subject)

    2/9/23 11:07:31 AM ET
    $ALGN
    Industrial Specialties
    Health Care